PNC Financial Services Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
PNC Financial Services Group's RIGL Position: Q3 2026 in Review
PNC Financial Services Group increased its Rigel Pharmaceuticals (RIGL) stake by 19% in Q3 2026, buying an estimated $217 and bringing the position to 32 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #4901.
PNC Financial Services Group first reported a position in RIGL in Q3 2014 and has held it in 29 quarters since. The position peaked at $64K in Q1 2015. 170 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.
- PNC Financial Services Group held 32 shares of Rigel Pharmaceuticals worth $1.54K as of Q3 2026.
- PNC Financial Services Group bought 5 Rigel Pharmaceuticals shares in Q3 2026, an estimated $217.
- Rigel Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4901 holding.
- PNC Financial Services Group first reported a position in Rigel Pharmaceuticals in Q3 2014 and has held it in 29 quarters since.
- PNC Financial Services Group's Rigel Pharmaceuticals position peaked at $64K in Q1 2015.
- 170 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.